EA201990755A1 - NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR APPLICATION IN THE IMMUNOTHERAPY OF Pancreatic Cancer and Other Cancer Species - Google Patents

NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR APPLICATION IN THE IMMUNOTHERAPY OF Pancreatic Cancer and Other Cancer Species

Info

Publication number
EA201990755A1
EA201990755A1 EA201990755A EA201990755A EA201990755A1 EA 201990755 A1 EA201990755 A1 EA 201990755A1 EA 201990755 A EA201990755 A EA 201990755A EA 201990755 A EA201990755 A EA 201990755A EA 201990755 A1 EA201990755 A1 EA 201990755A1
Authority
EA
Eurasian Patent Office
Prior art keywords
peptides
cells
cancer
immunotherapy
combinations
Prior art date
Application number
EA201990755A
Other languages
Russian (ru)
Inventor
Тони Вайншенк
Йенс Фритше
Харприт Сингх
Андреа Мар
Мартина Отт
Клаудиа Вагнер
Оливер Шор
Original Assignee
Имматикс Байотекнолоджиз Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Имматикс Байотекнолоджиз Гмбх filed Critical Имматикс Байотекнолоджиз Гмбх
Publication of EA201990755A1 publication Critical patent/EA201990755A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Изобретение относится к пептидам, белкам, нуклеиновым кислотам и клеткам для применения в иммунотерапевтических методах. В частности, настоящее изобретение относится к иммунотерапии рака. Настоящее изобретение относится далее к опухолеассоциированным пептидным эпитопам T-клеток, в отдельности или в комбинации с другими опухолеассоциированными пептидами, которые могут, например, служить в качестве активных фармацевтических ингредиентов вакцинных композиций, стимулирующих противоопухолевые иммунные ответы, или стимулировать T-клетки ex vivo с их перенесением в организм пациента. Пептиды, связанные с молекулами главного комплекса гистосовместимости (MHC), или пептиды в отдельности могут быть также мишенями антител, растворимых T-клеточных рецепторов и других связывающих молекул.The invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to cancer immunotherapy. The present invention further relates to tumor-associated peptide epitopes of T cells, alone or in combination with other tumor-associated peptides, which can, for example, serve as active pharmaceutical ingredients in vaccine compositions that stimulate antitumor immune responses, or stimulate ex vivo T cells with their transfer to the patient’s body. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides individually, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.

EA201990755A 2015-03-17 2016-03-17 NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR APPLICATION IN THE IMMUNOTHERAPY OF Pancreatic Cancer and Other Cancer Species EA201990755A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562134253P 2015-03-17 2015-03-17

Publications (1)

Publication Number Publication Date
EA201990755A1 true EA201990755A1 (en) 2019-08-30

Family

ID=59256519

Family Applications (4)

Application Number Title Priority Date Filing Date
EA202190897A EA202190897A3 (en) 2015-03-17 2016-03-17 NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF PANCREAS CANCER AND OTHER TYPES OF CANCER
EA202190898A EA202190898A3 (en) 2015-03-17 2016-03-17 NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF PANCREAS CANCER AND OTHER TYPES OF CANCER
EA201990755A EA201990755A1 (en) 2015-03-17 2016-03-17 NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR APPLICATION IN THE IMMUNOTHERAPY OF Pancreatic Cancer and Other Cancer Species
EA202190896A EA202190896A3 (en) 2015-03-17 2016-03-17 NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF PANCREAS CANCER AND OTHER TYPES OF CANCER

Family Applications Before (2)

Application Number Title Priority Date Filing Date
EA202190897A EA202190897A3 (en) 2015-03-17 2016-03-17 NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF PANCREAS CANCER AND OTHER TYPES OF CANCER
EA202190898A EA202190898A3 (en) 2015-03-17 2016-03-17 NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF PANCREAS CANCER AND OTHER TYPES OF CANCER

Family Applications After (1)

Application Number Title Priority Date Filing Date
EA202190896A EA202190896A3 (en) 2015-03-17 2016-03-17 NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF PANCREAS CANCER AND OTHER TYPES OF CANCER

Country Status (2)

Country Link
AR (2) AR103962A1 (en)
EA (4) EA202190897A3 (en)

Also Published As

Publication number Publication date
AR103962A1 (en) 2017-06-14
EA202190897A3 (en) 2021-10-29
EA202190898A3 (en) 2021-10-29
AR122383A2 (en) 2022-09-07
EA202190898A2 (en) 2021-07-30
EA202190896A3 (en) 2021-10-29
EA202190897A2 (en) 2021-07-30
EA202190896A2 (en) 2021-07-30

Similar Documents

Publication Publication Date Title
EA201891116A1 (en) NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR THE USE OF SEVERAL CANCER TYPES IN IMMUNOTHERAPY
EA201992664A3 (en) NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF OVARIAN CANCER AND OTHER TYPES OF CANCER
EA201890635A1 (en) PEPTIDES AND COMBINATIONS OF PEPTIDES FOR APPLICATION IN IMMUNOTHERAPY OF SMALL CELLS OF LUNG AND OTHER CANCER SPECIES
EA201891465A1 (en) PEPTIDES AND COMBINATIONS OF PEPTIDES FOR APPLICATION IN BREAST CANCER IMMUNOTHERAPY AND OTHER CANCER TYPES
EA201890440A1 (en) NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR APPLICATION IN IMMUNOTHERAPY OF PROSTATE CANCER AND OTHER CANCER TYPES
EA201891074A1 (en) NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR APPLICATION IN CLL IMMUNOTHERAPY AND OTHER CANCER TYPES
EA201891699A3 (en) NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR THE APPLICATION IN IMMUNOTHERAPY OF SEVERAL TUMOR SPECIES
EA201891638A1 (en) NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN NHL IMMUNOTHERAPY AND OTHER CANCER TYPES
EA201890027A1 (en) NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR APPLICATION OF EPITELIAL OVARIAN CANCER AND OTHER TYPE OF CANCER
EA201992416A1 (en) PEPTIDES AND COMBINATIONS OF PEPTIDES FOR APPLICATION IN IMMUNOTHERAPY OF LEUKOSIS AND OTHER TYPES OF CANCER
EA201891994A1 (en) Uterus Cancer Treatment
EA201890560A1 (en) NEW PEPTIDES, PEPTIDE COMBINATIONS AND FRAMEWORK FOR APPLICATION IN THE IMMUNOTHERAPEUTIC METHOD OF TREATING DIFFERENT CANCER TYPES
EA201791853A1 (en) NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR THE APPLICATION IN THE IMMUNOTHERAPY OF CANCER OF THE REFERRAL GLAND AND OTHER TYPES OF CANCER
EA201792044A1 (en) NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR APPLICATION IN LUNG CANCER IMMUNOTHERAPY, INCLUDING NON-SMALL CELL LUNG CANCER AND OTHER CANCER SPECIES
EA201792484A1 (en) NEW CELL EPITOPES AND COMBINATION OF CELL EPITOPES FOR USE OF MYELOMA AND OTHER CANCER IN IMMUNOTHERAPY
EA201792242A1 (en) NEW PEPTIDES AND COMBINATIONS OF PEPTIDES AND THEIR CARDS FOR USE IN COLORECTAL CARCINOMA AND OTHER CANCER IN IMMUNOTHERAPY
EA201891701A1 (en) PEPTIDES AND COMBINATIONS OF PEPTIDES FOR THE APPLICATION IN IMMUNOTHERAPY OF NON-SMALL CELL LUNG AND OTHER CANCER
EA201792531A1 (en) NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR APPLICATION IN IMMUNOTHERAPY AND METHODS OF OBTAINING FRAMEWORK FOR APPLICATION IN THE TREATMENT OF CANCER AND OTHER CANCER TYPES
EA201792671A1 (en) NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR THE USE OF EDUCATION AND OTHER SPECIES OF CANCER IN IMMUNOTHERAPY
EA201892333A1 (en) IMMUNOTHERAPY OF MELANOMA AND OTHER CANCER SPECIES
EA201892159A1 (en) NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR THE USE OF AML AND OTHER CANCER IN IMMUNOTHERAPY
EA201991444A1 (en) NEW PEPTIDES AND PEPTID COMBINATIONS FOR APPLICATION IN THE IMMUNOTHERAPY OF OVARIAN CANCER AND OTHER TYPES OF CANCER
MX2022005570A (en) Novel peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers.
EA201990755A1 (en) NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR APPLICATION IN THE IMMUNOTHERAPY OF Pancreatic Cancer and Other Cancer Species
EA202092502A2 (en) NEW PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY OF SEVERAL TYPES OF CANCER